1
TITLE: A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. MCTs as targets for prostate cancer therapy  Full Text
AUTHORS: Nelma Pertega Gomes; Sergio Felisbino; Charlie E Massie; Jose R Vizcaino; Ricardo Coelho; Chiranjeevi Sandi; Susana Simoes Sousa; Sarah Jurmeister; Antonio Ramos Montoya; Mohammad Asim; Maxine Tran; Elsa Oliveira ; Alexandre Lobo da Cunha; Valdemar Maximo ; Fatima Baltazar; David E Neal; Lee G D Fryer;
PUBLISHED: 2015, SOURCE: JOURNAL OF PATHOLOGY, VOLUME: 236, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 73
2
TITLE: Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer
AUTHORS: Pertega Gomes, N; Vizcaino, JR; Felisbino, S; Warren, AY; Shaw, G; Kay, J; Whitaker, H; Lynch, AG; Fryer, L; Neal, DE; Massie, CE;
PUBLISHED: 2015, SOURCE: Oncotarget, VOLUME: 6, ISSUE: 25
INDEXED IN: Scopus
3
TITLE: Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
AUTHORS: Vincent Zecchini; Basetti Madhu; Roslin Russell; Nelma Pertega Gomes; Anne Warren; Edoardo Gaude; Joana Borlido; Rory Stark; Heather Ireland Zecchini; Roheet Rao; Helen Scott; Joan Boren; Charlie Massie; Mohammad Asim; Kevin Brindle; John Griffiths; Christian Frezza; David E Neal; Ian G Mills;
PUBLISHED: 2014, SOURCE: EMBO JOURNAL, VOLUME: 33, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef